Clinical trial
Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover…
NCT00293150 · The Cleveland Clinic, Other · Terminated
Key facts
| NCT number | NCT00293150 |
|---|---|
| Title | Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure |
| Official title | Determine the Effectiveness of Eplerenone in Reversing Diastolic Dysfunction, Improving Endothelial Function, and Suppressing Natriuretic Peptides and Collagen Turnover in Patients With Diastolic Heart Failure ( PREDICT Study) |
| Acronym | PREDICT |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diastolic Heart Failure |
| Intervention type | Drug |
| Interventions | Eplerenone |
| Enrollment | 11 |
| Start date | Sep 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Feb 17, 2006 |
| Last update posted | Jan 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: